Clinical Trials
13 trialsNCT04798664 2026-02-25
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT01535040 2021-09-28
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Wake Forest University Health Sciences
Phase 2 Completed
NCT02648178 2019-09-19
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT02123849 2018-08-29
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
National Cancer Institute (NCI)
Phase 2 Completed
NCT00790569 2018-06-06
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Butler Hospital
Phase NA Completed
NCT00690924 2018-06-04
Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT00534001 2017-05-30
Bupropion in Helping Adults Stop Smoking
Roswell Park Cancer Institute
Phase 2 Completed
NCT00691132 2017-05-12
Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers
University of Minnesota
Phase 2 Completed
NCT00957424 2017-02-07
Acceptability of Less Harmful Alternatives to Cigarettes
Roswell Park Cancer Institute
Phase NA Completed
NCT00365508 2016-03-29
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Fox Chase Cancer Center
Phase 4 Completed
NCT00368927 2014-05-23
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed